Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation
Observational Cohort Study Of The Efficacy Of Preoperative Estimation Of Disc Herniation Recurrence In Patients With Lumbar Disc Herniation
1 other identifier
observational
386
1 country
2
Brief Summary
This study will be conducted at Research Institute of Traumatology and Orthopedics (NRITO) n.a. Ya.L.Tsivyan, Novosibirsk, Russia. The current study is prospective observational study to evaluate the efficacy of preoperative estimation of disc herniation recurrence among patients with lumbar disc herniation using predictive mathematical model at terms 3 years postoperatively . It is expected to enroll 350 patients aged 18-70 with lumbar disc herniation. Risk estimation of disc herniation recurrence will be evaluated preoperatively, then patient will undergo conventional microdiscectomy. Postoperative eximanation will include Visits every 6-months during 3 years to evaluate clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2020
CompletedFirst Posted
Study publicly available on registry
February 5, 2020
CompletedStudy Start
First participant enrolled
February 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedFebruary 27, 2026
February 1, 2026
3.5 years
February 1, 2020
February 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Reherniation rate
Rate of lumbar disc reherniation, symptomatic presence of disc herniation confirmed by MRI at the previously operated level and side
at 3 years follow-up term postoperatively
Secondary Outcomes (4)
Improvement of Oswestry Disability Index (ODI)
6, 12, 18, 24, 30, 36 months follow up
Improvement of Visual analog scale (VAS) leg pain intensity
6, 12, 18, 24, 30, 36 months follow up
Change from baseline in EQ-5D (EuroQl - 5 dimensional)
6, 12, 18, 24, 30, 36 months follow up
HTI Item (from SF-36)
6, 12, 18, 24, 30, 36 months follow up
Study Arms (2)
High risk recurrence group
Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.
Low risk recurrence group
Due to preoperative risk estimation each patient will be assigned to one of two groups - with high risk and low risk.
Interventions
Risk estimation of disc herniation recurrence will be evaluated preoperatively, depend on the risk significance each patient will be assigned to one of two groups - with high risk and low risk. Then each patient will undergo conventional one-level microdiscectomy.
Eligibility Criteria
Adult patients with radicular leg pain with or without back pain secondary to single level disc herniation with neural compression confirmed on MRI and symptoms persisting for at least four weeks prior to surgery
You may qualify if:
- \- Age 18 to 60 years;
- Single level lumbar disc herniation with neural compression confirmed on MRI at one level of L4-L5 or L5-S1;
- Radicular leg pain with or without back pain;
- Symptoms persisting for at least four weeks prior to surgery;
- Given written Informed Consent;
- Able and agree to fully comply with the clinical protocol and willing to adhere to follow-up schedule and requirements;
- Visual Analogue Scale score at least 40/100 at baseline.
You may not qualify if:
- More than one symptomatic level requiring multilevel surgical decompression
- Stenosis any etiology at the same level;
- Spondylolisthesis any etiology at the same level;
- Prior lumbar spinal surgery at any level;
- Other non-degenerative spinal conditions (e.g. infectious, traumatic, metabolic, inflammatory, neoplastic, structural or other pathology) that may have an impact on subject safety, wellbeing or the intent and conduct of the study
- Concurrent participation in another clinical study that may confound study results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Priorov National Medical Research Center of Traumatology and Orthopedics
Moscow, 127299, Russia
Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan
Novosibirsk, 630091, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Years
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2020
First Posted
February 5, 2020
Study Start
February 10, 2020
Primary Completion
August 10, 2023
Study Completion
February 25, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02